As the obesity crisis worsens and more pharmaceutical companies are hoping to improve their bottom line by shrinking their customers' bottoms. After all, we are a short-cut society (who wouldn't rather pop a pill than engage in the hard work of exercise and calorie restriction?) with a short memory (remember the fen-phen diet-drug combo that led to a gazillion lawsuits?). The good news is that according to a recent report in the British Medical Journal, three relatively new antiobesity drugs helped patients lose a moderate amount of weight while doing such things as lowering cholesterol and reducing the incidence of diabetes. The bad news is that the list of possible side effects doesn't end there.
Full Article on Time Magazine
